RAD51 and plasma cell myeloma: Reis and co-workers reported that PNA–NLS targeting the transcription start site of RAD51, protein that mediated recombinational DNA repair and is overexpressed in multiple myeloma, sensitized multiple myeloma cells to melphalan treatment [300].